These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32943992)

  • 1. Melatonin and urological cancers: a new therapeutic approach.
    Mehrzadi MH; Hosseinzadeh A; Juybari KB; Mehrzadi S
    Cancer Cell Int; 2020; 20():444. PubMed ID: 32943992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress.
    Mehrzadi S; Pourhanifeh MH; Mirzaei A; Moradian F; Hosseinzadeh A
    Cancer Cell Int; 2021 Mar; 21(1):188. PubMed ID: 33789681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Effects of Berberine against Urological Cancers: Biological Potentials Based on Cellular Mechanisms.
    Savoji AB; Kaheni Y; Rezaei P; Farkhondeh T; Pourhanifeh MH; Samarghandian S
    Curr Mol Med; 2023 Nov; ():. PubMed ID: 37933211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways.
    Pourhanifeh MH; Mehrzadi S; Kamali M; Hosseinzadeh A
    Eur J Pharmacol; 2020 Nov; 886():173471. PubMed ID: 32877658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role and Therapeutic Potential of Melatonin in Various Type of Cancers.
    Gurunathan S; Qasim M; Kang MH; Kim JH
    Onco Targets Ther; 2021; 14():2019-2052. PubMed ID: 33776451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer.
    Wojcik M; Krawczyk M; Wojcik P; Cypryk K; Wozniak LA
    Curr Med Chem; 2017 Nov; 24(35):3829-3850. PubMed ID: 28721827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence.
    Moradian F; Pourhanifeh MH; Mehrzadi S; Karimi-Behnagh A; Hosseinzadeh A
    Fundam Clin Pharmacol; 2022 Oct; 36(5):777-789. PubMed ID: 35384044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human hepatocellular carcinoma: Protection by melatonin.
    Mortezaee K
    J Cell Physiol; 2018 Oct; 233(10):6486-6508. PubMed ID: 29672851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives.
    Mafi A; Rismanchi H; Gholinezhad Y; Mohammadi MM; Mousavi V; Hosseini SA; Milasi YE; Reiter RJ; Ghezelbash B; Rezaee M; Sheida A; Zarepour F; Asemi Z; Mansournia MA; Mirzaei H
    Front Pharmacol; 2023; 14():1224151. PubMed ID: 37645444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin and non-small cell lung cancer: new insights into signaling pathways.
    Pourhanifeh MH; Sharifi M; Reiter RJ; Davoodabadi A; Asemi Z
    Cancer Cell Int; 2019; 19():131. PubMed ID: 31123430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative therapies for urological cancers.
    Inokuchi J; Yokomizo A; Nishiyama N; Kitamura H; Eto M; Nishiyama H; Tomita Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):357-367. PubMed ID: 32115649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
    Saito K; Kihara K
    Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyoxalases in Urological Malignancies.
    Antognelli C; Talesa VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
    Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
    Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin-A New Prospect in Prostate and Breast Cancer Management.
    Anim-Koranteng C; Shah HE; Bhawnani N; Ethirajulu A; Alkasabera A; Onyali CB; Mostafa JA
    Cureus; 2021 Sep; 13(9):e18124. PubMed ID: 34692334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin as a promising agent to treat ovarian cancer: molecular mechanisms.
    Chuffa LGA; Reiter RJ; Lupi LA
    Carcinogenesis; 2017 Oct; 38(10):945-952. PubMed ID: 28575150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin: new insights on its therapeutic properties in diabetic complications.
    Pourhanifeh MH; Hosseinzadeh A; Dehdashtian E; Hemati K; Mehrzadi S
    Diabetol Metab Syndr; 2020; 12():30. PubMed ID: 32280378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of melatonin in skin cancer treatment: A review of current biological evidence.
    Pourhanifeh MH; Mahdavinia M; Reiter RJ; Asemi Z
    J Cell Physiol; 2019 Aug; 234(8):12142-12148. PubMed ID: 30618091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy indications in the treatment of metastases from urological malignancies].
    Théodore C
    Prog Urol; 2008 Nov; 18 Suppl 7():S219-22. PubMed ID: 19070795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.